2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$15.59+$0.04 (+0.23%)
Price as of Oct 23, 2026 4:08 AM EDT- $12.6BMarket Cap
- -17.07%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$15.59+$0.04 (+0.23%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.55 | ||
Change | -$0.28 (-1.77%) | ||
Open | $15.29 | ||
High | $15.70 | ||
Low | $15.13 | ||
Previous Close | $15.83 | ||
Volume | 4,150,760 | ||
30-Day Average Volume | 6,754,997 | ||
1-Week Change | 1.17% | ||
1-Month Change | -9.17% | ||
1-Year Change | -17.07% | ||
3-Year Change | 740.54% | ||
5-Year Change | 212.25% | ||
Fundamentals | |||
Shares Outstanding | 797.7M | ||
Total Assets | $752.2M | ||
Market Cap | $12.6B | ||
Enterprise Value | $12.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$215.7M | ||
Free Cash Flow | -$142.0M | ||
EBIT | -$215.7M | ||
EBITDA | -$215.7M | ||
Net Working Capital | $617.0M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -57 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 20 | ||
P/E | -57 | ||
PEG | 3 | ||
Price/Free Cash Flow | -89 | ||
Price/Operating Cash Flow | -89 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue